Novartis AG ( NVSEF) - Key Metrics
NVSEF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $7.25 | $1.61 | $1.12 | $0.80 |
| 2025Q3 | $7.37 | $2.02 | $3.37 | $2.95 |
| 2025Q2 | $7.62 | $2.07 | $3.42 | $3.13 |
| 2025Q1 | ? | ? | ? | ? |
NVSEF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 3.36% | 21.51 |
| 2025Q3 | 5.55% | 15.58 |
| 2025Q2 | 61.49% | 14.61 |
| 2025Q1 | ? | ? |
NVSEF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.18% | ? |
| 2025Q4 | 0.58% | 0.04% |
| 2025Q3 | 2.38% | 0.09% |
| 2025Q2 | 2.61% | 1.05% |
| 2025Q1 | 1.57% | ? |
NVSEF
Price: $143.88
Dividend Yield: 3.29%
Forward Dividend Yield: 6.60%
Payout Ratio: 76.50%
Dividend Per Share: 9.51 USD
Earnings Per Share: 6.85 USD
P/E Ratio: 21.02
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 275.0 billion
Average Dividend Frequency: 2
Years Paying Dividends: 30
DGR3: 5.96%
DGR5: 5.16%
DGR10: 3.98%
DGR20: 7.45%